Sanofi S.A. acquired the target/assets from Vigil Neuroscience, Inc. in a acquisition on not available.
Deal value was 2200000000 Sector: Biotechnology; Location: USA.
On the acquirer side, counsel advised, led by Brock Dahl, Christine Lyon, Jenny Hochenberg, Jonathan Zhou, Kristen Riemenschneider, Mary Lehner, Nicole Foster, Sarah Katz, Steven Matays.
Generated by AI, original source from - Data is in progress
Vigil Neuroscience, Inc. advisor
Firm name is in progress
Found it useful? Spread the word.
Freshfields advises Sanofi S.A. on its acquisition of Vigil Neuroscience, Inc. | The Sponsor - The Sponsor
